Patrick Lundgren PhD

Board Observer

Patrick focuses on biotech investments at Hummingbird and leads incubations. He was previously an Associate at Flagship Pioneering, the VC firm that launched Moderna. At Flagship, he worked in venture creation to build and originate bioplatform companies. Before Flagship, Patrick completed his Ph.D. in immunology at the University of Pennsylvania, publishing 10+ papers including in Cell, Nature, and Nature Metabolism spanning adipocyte biology, immunology, and gut-brain signaling. Patrick also holds an M.Sc. in immunology from the University of Oxford (with Distinction), and a BA in Natural Sciences from the University of Cambridge.

A native Swede, Patrick grew up in Malmö, which prepared him well for Boston winters.